Global Edition news

By By Dave Muoio 02:14 pm July 16, 2020
Jerusalem-based Teva Pharmaceuticals announced this week the U.S. launch of its ProAir Digihaler. The sensor-laden albuterol dispenser requires a prescription, and is indicated for those aged four years or older with reversible obstructive airway diseases such as asthma and COPD, as well as for the prevention of exercise-induced bronchospasm (EIB) among this same group. The device connects to a...
By By Laura Lovett 02:13 pm July 16, 2020
Cityblock, a startup focused on used tech to tackling health disparities, has raised $53.5 million in what it describes as Series B+ funding. Kinnevik AB led the round with participation from AIMS Imprint of Goldman Sachs Asset Management and Alphabet, as well as existing investors.  This comes roughly a year after a $63 million Series B funding in April of 2019, and close to two years after the...
By By Mallory Hackett 03:30 pm July 15, 2020
Tabula Rasa HealthCare today launched MedWise on its PrescribeWellness platform for pharmacists to cumulatively compare how different medications interact with each other.  The company, which focuses on improving medication safety, developed this service to allow pharmacists to see how medications will work together on a larger scale than one-to-one. By doing this, Tabula Rasa says adverse drug...
By By Dave Muoio 03:19 pm July 15, 2020
Three health tech startups and spinouts announced today a merger to become a single entity focused on delivering virtual-care products and population health insights for seniors. Curavi Health, CarePointe and U.S. Health Systems (USHS) are set to become wholly owned subsidiaries of the new company, Arkos Health, and the executive teams of each will be merged. UPMC's existing stake in Curavi (...
By By Laura Lovett 03:16 pm July 15, 2020
Before Dr. Matthew Fradkin was a pediatrician he played in a punk rock band. Aside from the years of training to become a physician, he said there were actually some similarities to the two – namely the search for human connection. “They have the same core, the in-the-moment human connection is really important to both. Bringing back the human connection in medicine is where I see digital and AI...
By By Dave Muoio 12:10 pm July 15, 2020
Brisbane, California-based Caption Health, maker of artificial intelligence-assisted ultrasound guidance software, has tied up a $53 million Series B funding round. Prior backer DCVC headed the raise. Atlantic Bridge and Edwards Lifesciences joined the round as new investors, while Khosla Ventures added onto its previous stake. WHAT It DOES The company's Caption AI software platform consists of...
By By Dave Muoio 09:00 am July 15, 2020
GYANT, maker of an artificial intelligence-based virtual-healthcare assistant, has hauled in a $13.6 million Series A financing round. Wing Venture Capital headlined the raise, which also included support from Intermountain Ventures, Grazia Equity, Alpana Ventures, Techstars Ventures and Plug and Play Ventures. WHAT IT DOES A veteran of the Cedars-Sinai Tech Stars accelerator, GYANT's care-...
By By Laura Lovett 02:42 pm July 14, 2020
This morning digital pharmacy Medly announced the close of a $100 million Series B funding round. The new infusion of cash was led by Volition Capital and Greycroft with participation from Horsley Bridge and Lerer Hippeau. This comes roughly a year after the New York-based company announced the close of its Series A funding round, which was also led by Greycroft, for an undisclosed amount.  WHAT...
By By Mallory Hackett 02:27 pm July 14, 2020
Hale Health today launched Hale 2.0, a redesigned version of its remote-care platform in response to the increased demand of telemedicine in the pandemic. The company rebuilt the platform in an effort to simplify the user experience for both providers and patients and increase flexibility for providers through new features and better pricing options. The updated platform will integrate with...
By By Dave Muoio 02:24 pm July 14, 2020
Decentralized digital therapeutic trial. Pear Therapeutics has enrolled the first participant in the DREAM study, an open-label trial of its Somryst prescription digital therapeutic for chronic insomnia. Conducted as a decentralized trial, the effort will recruit U.S. adults aged 22 to 75 years who have an Insomnia Severity Index score of 8 or higher, as well as at least three months of insomnia...